CEO of Michi­gan CD­MO ex­plains how he nabbed mon­key­pox vac­cine con­tract

As US cas­es of the mon­key­pox out­break have now risen above 14,000, the gov­ern­ment is mov­ing quick­ly to make more dos­es avail­able, with the Jyn­neos vac­cine look­ing to be de­ployed wider as Bavar­i­an Nordic’s sites in Eu­rope get the all-clear from the FDA.

Mean­while, a Grand Rapids, Michi­gan-based CD­MO land­ed a deal with Bavar­i­an Nordic, to fill and fin­ish the vac­cine. Grand Riv­er Asep­tic Man­u­fac­tur­ing, a rel­a­tive­ly new play­er in the CD­MO world, on­ly be­ing around since 2010, an­nounced it re­ceived the deal from Bavar­i­an Nordic as well as ap­proval from HHS and BAR­DA to in­crease the do­mes­tic sup­ply of Jyn­neos.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER